Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 29-Dec-23 4:35 PM View:  | Adventrx Pharmaceuticals Inc. (SVRA) | 28-Dec-23 | Gift | 19,000 | -- | -- | (1%) 1.39M to 1.37M | |
| 29-Dec-23 4:35 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 28-Dec-23 | Sale | 84,000 | $4.71 | $395,900.00 | (6%) 1.37M to 1.28M | |
| 15-Dec-23 5:46 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 14-Dec-23 | Grant | 450,000 | -- | -- | 43% 1.05M to 1.5M | |
| 15-Dec-23 5:46 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 14-Dec-23 | Payment of Exercise | 109,680 | $4.45 | $488,076.00 | (7%) 1.5M to 1.39M | |
| 15-Dec-22 4:06 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 13-Dec-22 | Grant | 325,000 | -- | -- | 45% 721.35K to 1.05M | |
| 03-Jan-22 4:10 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 31-Dec-21 | Payment of Exercise | 62,318 | $1.24 | $77,274.30 | (8%) 783.67K to 721.35K | (5%) |
| 14-Dec-21 6:31 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 14-Dec-21 | Grant | 400,000 | -- | -- | 104% 383.67K to 783.67K | |
| 08-Dec-21 2:41 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 08-Dec-21 | Market Purchase | 6,500 | $1.06 | $6,889.35 | 2% 377.17K to 383.67K | (< 1%) |
| 02-Dec-21 12:28 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 02-Dec-21 | Market Purchase | 10,000 | $1.10 | $10,954.00 | 3% 367.17K to 377.17K | (1%) |
| 22-Nov-21 11:42 AM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 19-Nov-21 | Market Purchase | 12,150 | $1.10 | $13,389.80 | 3% 355.02K to 367.17K | (2%) |
| 22-Nov-21 11:42 AM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 18-Nov-21 | Market Purchase | 10,000 | $1.10 | $11,000.00 | 3% 345.02K to 355.02K | (< 1%) |
| 18-Aug-21 4:03 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 18-Aug-21 | Market Purchase | 11,900 | $1.19 | $14,165.80 | 4% 333.12K to 345.02K | (< 1%) |
| 18-Aug-21 4:03 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 17-Aug-21 | Market Purchase | 15,000 | $1.18 | $17,700.00 | 5% 318.12K to 333.12K | 0% |
| 24-May-21 8:10 AM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 21-May-21 | Market Purchase | 10,000 | $1.63 | $16,298.00 | 3% 308.12K to 318.12K | 5% |
| 19-Apr-21 2:46 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 19-Apr-21 | Market Purchase (Planned) | 27,400 | $1.82 | $49,870.70 | 10% 280.72K to 308.12K | (4%) |
| 22-Mar-21 9:47 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 22-Mar-21 | Market Purchase (Planned) | 24,100 | $2.07 | $49,937.60 | 9% 256.62K to 280.72K | (< 1%) |
| 23-Feb-21 9:48 AM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 22-Feb-21 | Market Purchase (Planned) | 28,700 | $1.74 | $50,038.40 | 13% 227.92K to 256.62K | (< 1%) |
| 15-Sep-20 9:45 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 15-Sep-20 | Grant | 227,272 | -- | -- | 34965% 0.65K to 227.92K | |
| 21-May-20 4:31 PM View: | Zyla Life Sciences (ZCOR) | 20-May-20 | Disposition | 26,953 | -- | -- | (100%) 26.95K to 0 | |
| 24-Apr-20 6:12 PM View: | Zyla Life Sciences (ZCOR) | 23-Apr-20 | Payment of Exercise | 952 | $1.75 | $1,666.00 | (14%) 6.67K to 5.71K | |
| 24-Apr-20 6:12 PM View: | Zyla Life Sciences (ZCOR) | 23-Apr-20 | Option Exercise | 6,667 | $1.75 | $11,667.20 | 100% 0 to 6.67K | |
| 05-Mar-20 8:41 PM View: | Zyla Life Sciences (ZCOR) | 04-Mar-20 | Grant | 13,620 | -- | -- | 100% 0 to 13.62K | |
| 24-Apr-19 8:53 PM View: | Zyla Life Sciences (ZCOR) | 23-Apr-19 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 22-Feb-19 8:50 AM View: | Strongbridge Biopharma Plc (SBBP) | 20-Feb-19 | Grant | 50,000 | -- | -- | 221% 22.61K to 72.61K | |
| 28-Feb-18 2:37 PM View: | Strongbridge Biopharma Plc (SBBP) | 26-Feb-18 | Payment of Exercise | 17,392 | $6.60 | $114,787.00 | (43%) 40.0K to 22.61K | |
| 15-Sep-20 9:45 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 27-Apr-17 | Option Exercise | 650 | -- | -- | 100% 0 to 0.65K |